🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Temenos shares target dropped by Citi amid guidance miss and strategic uncertainties

EditorEmilio Ghigini
Published 07/26/2024, 03:22 PM
TMSNY
-

On Friday, Citi adjusted its price target Temenos AG (TEMN:SW) (OTC: TMSNY), decreasing it slightly to CHF66.00 from the previous CHF67.00. The firm maintained a Neutral rating on the stock.

The revision follows Temenos's announcement of a second-quarter top-line miss and a lowered guidance, which has been a point of focus despite some signs of deal closure normalization towards the quarter's end.

Citi's current stance reflects a cautious outlook, factoring in the uncertainties stemming from the ongoing leadership transition at Temenos, the ambitious targets set during the company's Capital Markets Day (CMD), and the challenging objectives for fiscal year 2024. Despite these concerns, Citi acknowledges that the measures discussed during the company's earnings call and group meeting indicate progress.

The financial services firm also indicated that it had previously held expectations below the prior guidance range, which had informed its earlier negative coverage on the stock. With the new developments, Citi has made further downward adjustments to its projections for Temenos.

Investors and stakeholders are advised to look forward to the CMD in November for a more comprehensive update on Temenos's new strategy, key performance indicators, and areas of investment. The forthcoming details are anticipated to provide greater clarity on the company's direction and potential for growth.

In other recent news, Temenos AG has seen significant changes in its financial outlook and stock rating. BofA Securities downgraded the company's stock from Buy to Neutral, lowering the price target to CHF68.00 from CHF89.00 in response to underperformance in recent quarters. The company's second-quarter revenues fell short of expectations by 3%, following a 5% shortfall in the first quarter, primarily driven by weak subscription growth.

Temenos AG's total software licensing revenue for 2024 was reported at $102 million, a 1% decrease year-over-year. This downturn, largely attributed to a report by Hindenburg Research, led to a substantial 50% drop in term license sales.

Consequently, the company has revised its full-year 2024 outlook, expecting total software licensing growth to range between 3% and 6%, a downward adjustment from the previously estimated 7% to 10%.

CFRA has maintained a Sell rating on Temenos stock, despite raising the price target to CHF56.00 from the previous CHF52.00. The firm's analysis suggests that Temenos may face a challenging year in 2024 due to volatile operating conditions and an uncertain macroeconomic outlook that may limit banking sector IT spending. These recent developments highlight the ongoing changes in the financial landscape that investors must navigate.

InvestingPro Insights

Amid the backdrop of Citi's revised outlook on Temenos AG, current metrics from InvestingPro paint a detailed picture of the company's financial position. Temenos AG has a market capitalization of $5.02 billion and is trading at a high P/E ratio of 37.28, suggesting a premium valuation relative to its earnings. Notably, the company has demonstrated a commitment to shareholder returns, having raised its dividend for 12 consecutive years, a testament to its financial resilience and management's confidence in its business model.

InvestingPro Tips indicate that while Temenos's stock has experienced a significant decline over the last week and six months, analysts remain optimistic about its profitability in the current year. This optimism is supported by the company's solid gross profit margin of nearly 66% over the last twelve months as of Q2 2024, underscoring its ability to maintain profitability despite market fluctuations. For investors seeking further insights and analysis, InvestingPro offers additional tips on Temenos AG, which can be accessed with a special offer using the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.